logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2019 — Tumor markers for advanced renal cell carcinoma may inform personalized therapy

Cohorts from the JAVELIN Renal 101 trial are investigated for an association between tumor markers and outcomes.